Treatment patterns and immunological parameters from the SPOCS study in Germany
Introduction: The international SLE Prospective Observational Cohort Study (SPOCS) collected data on patients with moderate to severe SLE disease in eight countries, of which one was Germany. SPOCS was performed before anifrolumab became available. Type 1 interferon signature status (IFNGS) was analyzed [for full text, please go to the a.m. URL]
Institutions
- AstraZeneca (France) (FR)
- AstraZeneca (Italy) (IT)
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-09-18
- DOI
- https://doi.org/10.3205/24dgrh193
- Primary Topic
- Species Distribution and Climate Change
- Type
- article
- Field-Weighted Citation Impact
- 0.00